Engerix B Versus Sci-B-Vac Immunization in a Celiac Population of Non-responders to Primary Hepatitis B Immunization Series - a Randomized Controlled Trial.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic
- 17 Apr 2011 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 22 Jul 2010 New trial record